Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-039051
Filing Date
2022-06-23
Accepted
2022-06-23 18:11:54
Documents
1
Period of Report
2022-06-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4029
  Complete submission text file 0001209191-22-039051.txt   5557
Mailing Address C/O PELOTON THERAPEUTICS, INC. 2330 INWOOD ROAD, SUITE 226 DALLAS TX 75235
Business Address
Josey John A. (Reporting) CIK: 0001776351 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40431 | Film No.: 221036554

Mailing Address 395 OYSTER POINT BLVD STE 217 SOUTH SAN FRANCISCO CA 94080-1930
Business Address 395 OYSTER POINT BLVD STE 217 SOUTH SAN FRANCISCO CA 94080-1930 206-913-4300
Day One Biopharmaceuticals, Inc. (Issuer) CIK: 0001845337 (see all company filings)

EIN.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations